Abstract
Antiviral innate immunity is initiated in response to RNA molecules that are produced in virus-infected cells1. These RNAs activate signalling cascades that activate the genes that encode α- and β-interferon (IFN). Signalling occurs through the interaction of the RNAs with either of two pathogen recognition receptors, retinoic acid-inducible gene-I (RIG-I, also known as DDX58) and melanoma differentiation associated gene-5 (MDA5, also known as IFIH1), which contain amino-terminal caspase activation and recruitment domains (CARD) and carboxy-terminal DExD/H Box RNA helicase motifs2,3,4,5. RIG-I and MDA5 interact with another CARD protein, interferon-β promotor stimulator protein-1 (IPS-1, also known as MAVS, VISA and Cardif), in the mitochondrial membrane, which relays the signal through the transcription factors interferon regulatory factor 3 (IRF-3) and nuclear factor (NF)-κB to the IFN-β gene6,7,8,9,10. Although the signalling pathway is well understood, the origin of the RNA molecules that initiate these processes is not. Here we show that activation of the antiviral endoribonuclease, RNase L11, by 2′,5′-linked oligoadenylate (2-5A)12 produces small RNA cleavage products from self-RNA that initiate IFN production. Accordingly, mouse embryonic fibroblasts lacking RNase L were resistant to the induction of IFN-β expression in response to 2-5A, dsRNA or viral infection. Single-stranded regions of RNA are cleaved 3′ of UpUp and UpAp sequences by RNase L during viral infections, resulting in small, often duplex, RNAs13,14. We show that small self-RNAs produced by the action of RNase L on cellular RNA induce IFN-β expression and that the signalling involves RIG-I, MDA5 and IPS-1. Mice lacking RNase L produce significantly less IFN-β during viral infections than infected wild-type mice. Furthermore, activation of RNase L with 2-5A in vivo induced the expression of IFN-β in wild-type but not RNase L-deficient mice. Our results indicate that RNase L has an essential role in the innate antiviral immune response that relieves the requirement for direct sensing of non-self RNA.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
ROGUE: an R Shiny app for RNA sequencing analysis and biomarker discovery
BMC Bioinformatics Open Access 29 July 2023
-
Occludin Regulates HIV-1 Infection by Modulation of the Interferon Stimulated OAS Gene Family
Molecular Neurobiology Open Access 20 May 2023
-
RBP–RNA interactions in the control of autoimmunity and autoinflammation
Cell Research Open Access 05 January 2023
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout




References
Saito, T. & Gale, M. Principles of intracellular viral recognition. Curr. Opin. Immunol. 19, 17–23 (2007)
Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature Immunol. 5, 730–737 (2004)
Kato, H. et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23, 19–28 (2005)
Gitlin, L. et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl Acad. Sci. USA 103, 8459–8464 (2006)
Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101–105 (2006)
Kawai, T. et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nature Immunol. 6, 981–988 (2005)
Seth, R. B., Sun, L., Ea, C. K. & Chen, Z. J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF 3. Cell 122, 669–682 (2005)
Xu, L. G. et al. VISA is an adapter protein required for virus-triggered IFN-β signaling. Mol. Cell 19, 727–740 (2005)
Meylan, E. et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167–1172 (2005)
Loo, Y. M. et al. Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infection. Proc. Natl Acad. Sci. USA 103, 6001–6006 (2006)
Zhou, A., Hassel, B. A. & Silverman, R. H. Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 72, 753–765 (1993)
Kerr, I. M. & Brown, R. E. pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc. Natl Acad. Sci. USA 75, 256–260 (1978)
Wreschner, D. H., McCauley, J. W., Skehel, J. J. & Kerr, I. M. Interferon action–sequence specificity of the ppp(A2'p)nA-dependent ribonuclease. Nature 289, 414–417 (1981)
Han, J. Q., Wroblewski, G., Xu, Z., Silverman, R. H. & Barton, D. J. Sensitivity of hepatitis C virus RNA to the antiviral enzyme ribonuclease L is determined by a subset of efficient cleavage sites. J. Interferon Cytokine Res. 24, 664–676 (2004)
Zhou, A. et al. Interferon action and apoptosis are defective in mice devoid of 2',5′-oligoadenylate-dependent RNase L. EMBO J. 16, 6355–6363 (1997)
Dong, B. et al. Intrinsic molecular activities of the interferon-induced 2–5A-dependent RNase. J. Biol. Chem. 269, 14153–14158 (1994)
Kumar, H. et al. Essential role of IPS-1 in innate immune responses against RNA viruses. J. Exp. Med. 203, 1795–1803 (2006)
Yoneyama, M. et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175, 2851–2858 (2005)
Sumpter, R. et al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79, 2689–2699 (2005)
Thakur, C. S., Xu, Z., Wang, Z., Novince, Z. & Silverman, R. H. A convenient and sensitive fluorescence resonance energy transfer assay for RNase L and 2',5′ oligoadenylates. Methods Mol. Med. 116, 103–113 (2005)
Hornung, V. et al. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314, 994–997 (2006)
Pichlmair, A. et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314, 997–1001 (2006)
Saito, T. et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc. Natl Acad. Sci. USA 104, 582–587 (2007)
Malathi, K. et al. A transcriptional signaling pathway in the IFN system mediated by 2'-5′-oligoadenylate activation of RNase L. Proc. Natl Acad. Sci. USA 102, 14533–14538 (2005)
Kubota, K. et al. Identification of 2'-phosphodiesterase, which plays a role in the 2–5A system regulated by interferon. J. Biol. Chem. 279, 37832–37841 (2004)
Arimoto, K. et al. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc. Natl Acad. Sci. USA 104, 7500–7505 (2007)
Flodstrom-Tullberg, M. et al. RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J. Immunol. 174, 1171–1177 (2005)
Samuel, M. A. et al. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J. Virol. 80, 7009–7019 (2006)
Urisman, A. et al. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2, e25 (2006)
Beattie, E. et al. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69, 499–505 (1995)
Acknowledgements
We thank M. Diamond and M. Colonna (St Louis, Missouri, USA) for the Mda5–/– MEFs, S. Akira (Osaka, Japan) for Ips1–/– and Rig-i–/– cells, M. David (San Diego, California, USA) for IRF3 antibodies, C.M. Rice (New York, New York, USA) for Huh7 and Huh7.5 cells, I.M. Kerr (London, UK) for EMCV, P.J. Sims (Rochester, New York, USA) for discussions, and (all from Cleveland, Ohio, USA) G. Sen for Sendai virus, J. Paranjape for cell line preparations and RNA chip analysis, B.K. Jha for RNase L, B.K. Jha, C. Thakur and Z. Novince for preparing 2-5A, and S. Shelby for technical assistance with mice. These studies were supported by grants from the NIH to R.H.S. and M.G. and by a grant from the Burroughs Wellcome Fund to M.G.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests.
Supplementary information
Supplementary Information
This file contains Supplementary Figures S1-S4 with Legends. (PDF 229 kb)
Rights and permissions
About this article
Cite this article
Malathi, K., Dong, B., Gale, M. et al. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448, 816–819 (2007). https://doi.org/10.1038/nature06042
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature06042
This article is cited by
-
ROGUE: an R Shiny app for RNA sequencing analysis and biomarker discovery
BMC Bioinformatics (2023)
-
RBP–RNA interactions in the control of autoimmunity and autoinflammation
Cell Research (2023)
-
Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction
Nature Cancer (2023)
-
Occludin Regulates HIV-1 Infection by Modulation of the Interferon Stimulated OAS Gene Family
Molecular Neurobiology (2023)
-
Viral long non-coding RNA regulates virus life-cycle and pathogenicity
Molecular Biology Reports (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.